Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001013762-25-004330

Director acquired 2,716,898 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
M33 Growth I L.P. Director 2025-03-26 Grant or award +2,716,898 $1.04 $2,830,193 16,420,701 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
M33 Growth I L.P. Director 2025-03-26 Grant or award · Warrant to Purchase Shares of Common Stock +1,358,449 $0.13 $169,806 1,358,449 D: show line 2 in the form
Loading xslF345X05/ownership.xml…